# NB Bancorp, Inc.: financial statements, quarterly

NBBK · Nasdaq · CIK 1979330 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nbbk.md) · [Financials](/companies/nbbk/financials.md) · [Filings](/companies/nbbk/filings.md) · [Insiders](/companies/nbbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nbbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [26.1](/filings/0001558370-23-019309.md) | [29.0 d](/filings/0001558370-24-004193.md) | [29.6](/filings/0001558370-24-007722.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.1](/filings/0001558370-24-015066.md) | [(6.5) d](/filings/0001104659-26-022367.md) | [3.4](/filings/0001558370-25-007140.md) | [2.4](/filings/0001558370-25-010862.md) | [7.0](/filings/0001104659-25-108388.md) | [3.7 d](/filings/0001104659-26-022367.md) | [4.9](/filings/0001104659-26-057822.md) | [4.1](/filings/0001104659-26-092573.md) | [4.6](/filings/0001104659-25-108388.md) | [7.2 d](/filings/0001104659-26-022367.md) | [5.4](/filings/0001104659-26-057822.md) | [6.4](/filings/0001104659-26-092573.md) |
| Net income | $m | [8.5](/filings/0001558370-24-015066.md) | [(13.6) d](/filings/0001104659-26-022367.md) | [8.7](/filings/0001558370-25-007140.md) | [9.5](/filings/0001558370-25-010862.md) | [8.4](/filings/0001104659-25-108388.md) | [15.6 d](/filings/0001104659-26-022367.md) | [12.7](/filings/0001104659-26-057822.md) | [14.6](/filings/0001104659-26-092573.md) | [15.4](/filings/0001104659-25-108388.md) | [7.7 d](/filings/0001104659-26-022367.md) | [15.0](/filings/0001104659-26-057822.md) | [21.1](/filings/0001104659-26-092573.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.22](/filings/0001558370-25-007140.md) | [0.24](/filings/0001558370-25-010862.md) | [0.21](/filings/0001104659-25-108388.md) | not reported | [0.33](/filings/0001104659-26-057822.md) | [0.39](/filings/0001104659-26-092573.md) | [0.43](/filings/0001104659-25-108388.md) | not reported | [0.36](/filings/0001104659-26-057822.md) | [0.53](/filings/0001104659-26-092573.md) |
| Basic EPS | $ per share | not reported | not reported | [0.22](/filings/0001558370-25-007140.md) | [0.24](/filings/0001558370-25-010862.md) | [0.21](/filings/0001104659-25-108388.md) | not reported | [0.33](/filings/0001104659-26-057822.md) | [0.39](/filings/0001104659-26-092573.md) | [0.43](/filings/0001104659-25-108388.md) | not reported | [0.37](/filings/0001104659-26-057822.md) | [0.53](/filings/0001104659-26-092573.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [4,232](/filings/0001558370-23-019309.md) | [4,533](/filings/0001558370-25-002457.md) | [4,650](/filings/0001558370-24-007722.md) | [4,805](/filings/0001558370-24-011709.md) | [5,003](/filings/0001558370-24-015066.md) | [5,158](/filings/0001104659-26-022367.md) | [5,242](/filings/0001558370-25-007140.md) | [5,227](/filings/0001558370-25-010862.md) | [5,442](/filings/0001104659-25-108388.md) | [7,006](/filings/0001104659-26-092573.md) | [7,226](/filings/0001104659-26-057822.md) | [7,447](/filings/0001104659-26-092573.md) |
| Total liabilities | $m | [3,866](/filings/0001558370-23-019309.md) | [3,775](/filings/0001558370-25-002457.md) | [3,916](/filings/0001558370-24-007722.md) | [4,061](/filings/0001558370-24-011709.md) | [4,255](/filings/0001558370-24-015066.md) | [4,393](/filings/0001104659-26-022367.md) | [4,503](/filings/0001558370-25-007140.md) | [4,489](/filings/0001558370-25-010862.md) | [4,705](/filings/0001104659-25-108388.md) | [6,147](/filings/0001104659-26-092573.md) | [6,384](/filings/0001104659-26-057822.md) | [6,605](/filings/0001104659-26-092573.md) |
| Shareholders' equity | $m | [366](/filings/0001558370-24-015066.md) | [758](/filings/0001104659-26-022367.md) | [734](/filings/0001558370-25-010862.md) | [734](/filings/0001104659-25-108388.md) | [747](/filings/0001104659-25-108388.md) | [765](/filings/0001104659-26-092573.md) | [740](/filings/0001104659-26-092573.md) | [737](/filings/0001104659-26-092573.md) | [737](/filings/0001104659-25-108388.md) | [859](/filings/0001104659-26-092573.md) | [843](/filings/0001104659-26-092573.md) | [842](/filings/0001104659-26-092573.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.4 d](/filings/0001558370-24-015066.md) | [13.2 d](/filings/0001104659-26-022367.md) | [(11.4)](/filings/0001558370-25-007140.md) | [24.7 d](/filings/0001558370-25-010862.md) | [8.6 d](/filings/0001104659-25-108388.md) | [21.3 d](/filings/0001104659-26-022367.md) | [9.9](/filings/0001104659-26-057822.md) | [27.0 d](/filings/0001104659-26-092573.md) | [24.2 d](/filings/0001104659-25-108388.md) | [(0.4) d](/filings/0001104659-26-022367.md) | [27.3](/filings/0001104659-26-057822.md) | [34.2 d](/filings/0001104659-26-092573.md) |
| Capital expenditure | $m | [0.7 d](/filings/0001558370-24-015066.md) | [0.2 d](/filings/0001104659-26-022367.md) | [0.3](/filings/0001558370-25-007140.md) | [0.9 d](/filings/0001558370-25-010862.md) | [0.2 d](/filings/0001104659-25-108388.md) | [0.6 d](/filings/0001104659-26-022367.md) | [0.1](/filings/0001104659-26-057822.md) | [0.9 d](/filings/0001104659-26-092573.md) | [0.3 d](/filings/0001104659-25-108388.md) | [2.1 d](/filings/0001104659-26-022367.md) | [2.0](/filings/0001104659-26-057822.md) | [2.9 d](/filings/0001104659-26-092573.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.8 d](/filings/0001104659-26-022367.md) | [3.2](/filings/0001104659-26-057822.md) | [3.1 d](/filings/0001104659-26-092573.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [40.7](/filings/0001104659-26-057822.md) | [18.9 d](/filings/0001104659-26-092573.md) | [17.5 d](/filings/0001104659-25-108388.md) | [0.0 d](/filings/0001104659-26-022367.md) | [27.8](/filings/0001104659-26-057822.md) | [18.5 d](/filings/0001104659-26-092573.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.7](/filings/0001558370-25-007140.md) | [39.3](/filings/0001558370-25-010862.md) | [39.3](/filings/0001104659-25-108388.md) | [38.8](/filings/0001104659-26-057822.md) | [37.6](/filings/0001104659-26-092573.md) | [35.6](/filings/0001104659-25-108388.md) | [41.4](/filings/0001104659-26-057822.md) | [40.0](/filings/0001104659-26-092573.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 43,818,490 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092573.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.